Project Grant R21AI193590
Award Date 8/6/25
Completion Date 7/31/27
Dollars Obligated $224K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
South Carolina, USA
Similar Awards
- This federal Project Grant award of $612,328 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to enhance the understanding of mast cell lineage commitment and function. The research aims to determine how the transcription factor MITF maintains mast cell-specific gene expression and suppresses basophil-specific gene expression, as well as evaluate the functional deficiencies of mast...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $497,136 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Sloan-Kettering Institute for Cancer Research. The grant supports research to investigate the role of mast cells in regulating the inflammatory pathology of secondary lymphedema, a chronic and debilitating condition that commonly occurs following cancer treatments. The research aims to better understand the underlying...
- This Project Grant award of $431,147 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the mechanisms behind infusion reactions associated with monoclonal antibody (mAb) therapies. The research aims to elucidate the pathophysiological processes driving the rapid release of inflammatory cytokines that can lead to severe infusion reactions in some patients during mAb...
- This $612,917 federal Project Grant was awarded on July 23, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to investigate the role of the SIGLEC-9 receptor in regulating mast cell function and its potential for therapeutic targeting to treat mast cell-associated disorders such as...
- This federal Project Grant award of $586,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the generation and regulation of TFH13 cells that drive pathogenic IgE in allergic conditions. The overarching goal is to elucidate the pathways leading to TFH13 cell differentiation, which play a critical...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research grant program (CFDA 93.855), provides $463,676 to the University of Maryland, Baltimore for research to enhance the understanding of Fc-mediated effector functions in the context of infectious diseases. The project aims to dissect the mechanisms underpinning Fc-mediated effector functions, with a focus on antibody interactions with a...
- The University of Southern California (USC) was awarded a $207,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant supports research to investigate the role of the MIF/CD74 pathway in group 2 innate lymphoid cells (ILC2) and its contribution to the development of airway hyperreactivity, a key feature of allergic asthma. The research aims to provide a molecular...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $164,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Albany Medical College. The grant supports research to identify and characterize additional conformer-specific anti-I-A monoclonal antibodies (mAbs) to study the structure and function of MHC class II molecules, which are important for T cell-mediated immune responses. The research aims to address limitations in existing...
- This federal Project Grant award of $658,657, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at the University of Virginia on the biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells. The research aims to reveal the mechanisms by which protein condensates and membrane domains cooperatively regulate T-cell signal transduction and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $743,752 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Utah. The grant will support research to define how chronic antigen stimulation contributes to epigenetic programming that drives dysfunction in virus-specific CD4+ T cells during chronic viral infection. The project aims to use highly innovative in vivo models and whole genome DNA methylation sequencing...